The Tablet Project

 This project has been in planning for 4 years. Initially the idea came from the eMocha Project in Kenya where ODK (Open Data Kit) was used to collect information about patients using the original G1 Android phone.

The application in Oncology was to use a smart device to collct data from patients, and particularly to use the technology to collect a lot of data to demographically define the patient. This desire comes from the example provided by the Erlotinib (Iressa) Lung Cancer Trial which demonstarted that responders were identified accurately by the combination of 'female,'asian', non-smoker' and 'adenocarcinoma'. More recently, response to crizotinib is predicted by 'young', 'non-smoker' and 'adenocarcinoma', which is further defined by the mutated ALK gene. How much more demographic data is useful in selecting treatment? The reason for this usefulness is that some of the demographic data is phenotypic, that is, it is determined by the genetic makeup of the patient. It is theoretically possible that certain physical characteristics will reveal idiosyncracity in genetic make up.

The Tablet Project is being developed as part of the PROMPT Project funded by the Cancer Institute NSW in collaboration with Liverpool. The aim of that project is to use the Tablet Project's framework to address issues of survivorship (an area not originally detailed for use). The presentation of the Tablet Project data into the clincial environment is likely to revolutionise workflow for users of MOSAIQ. 

The attached PPT file shows the portions of the project as is now applied to the PROMPT Project.